REFERENCES
- Dearden C E, Foss F M. Peripheral T-cell lymphomas: diagnosis and management. Hematol Oncol Clin North Am 2003; 17: 1351–1366
- Bekkenk MW, Jansen PM, Meijer CJ, et al. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004; 15: 1097–1108
- Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol 2004; 28: 719–735
- Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas: report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003; 97: 610–627
- Willemze R, Jaffe E S, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785
- Kanegane H, Nomura K, Miyawaki T, et al. Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. Crit Rev Oncol Hematol 2002; 44: 239–249
- Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003; 187: 527–533
- Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005; 80: 64–69
- Yachie A, Kanegane H, Kasahara Y. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases. Semin Hematol 2003; 40: 124–132
- Smoller B R, Santucci M, Wood G S, et al. Histopathology and genetics of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 2003; 17: 1277–1311
- Go R S, Wester S M. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer 2004; 101: 1404–1413
- Kim G E, Koom W S, Yang W I, et al. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck 2004; 26: 584–593
- Li C C, Tien H F, Tang J L, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004; 100: 366–375
- Chan J K, Sin V C, Wong K F, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–4513
- Suzumiya J, Takeshita M, Kimura N. Sinonasal malignant lymphoma of natural killer cell phenotype associated with diffuse pancreatic involvement. Leuk Lymphoma 1993; 10: 231–236
- Hamzaoui M, Essid A, Sahli S, et al. Nasal angiocentric T cell-natural killer cell lymphoma with pancreatic localisation in a child. Arch Pediatr 2003; 10: 979–982
- Kuwabara H, Tsuji M, Yoshii Y, et al. Nasal-type NK/T cell lymphoma of the orbit with distant metastases. Hum Pathol 2003; 34: 290–292
- Wex H, Aumann V, Hausler M, et al. Chronic natural killer cell lymphocytosis is associated with elevated cytotoxic activity of natural killer cells. J Pediatr Hematol Oncol 2005; 27: 85–89
- Kimura H, Hoshino Y, Hara S, et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 2005; 191: 531–539
- Suzuki K, Ohshima K, Karube K, et al. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 2004; 24: 1165–1174